Related Experiment Video
Updated: Aug 1, 2025

07:55
Pancreatic Tissue-Derived Extracellular Matrix Bioink for Printing 3D Cell-Laden Pancreatic Tissue Constructs
Published on: December 13, 2019
11.0K
Recent Advances in Decellularized Extracellular Matrix-Based Bioinks for 3D Bioprinting in Tissue Engineering
Man Zhe1, Xinyu Wu2, Peiyun Yu3
1Animal Experiment Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Materials (Basel, Switzerland)
|April 28, 2023
Summary
Decellularized extracellular matrix (dECM) shows promise as a bioink for 3D bioprinting tissue substitutes. This review explores dECM bioinks, bioprinting techniques, and decellularization methods for tissue engineering applications.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Three-dimensional (3D) bioprinting is a key technology for creating complex tissue substitutes.
- Decellularized extracellular matrix (dECM) is a natural biomaterial rich in bioactive factors crucial for tissue regeneration.
- dECM-derived bioinks offer advantages over other bioinks due to their inherent signaling capabilities.
Purpose of the Study:
- To review the current advancements and future perspectives of decellularized extracellular matrix (dECM)-based bioinks in 3D bioprinting.
- To discuss the application of dECM bioinks for constructing tissue substitutes in tissue engineering.
Main Methods:
- Review of existing literature on dECM bioinks, 3D bioprinting techniques, and decellularization processes.
- Analysis of the properties and benefits of dECM components in modulating cellular functions and tissue remodeling.
Main Results:
- dECM bioinks possess complex structures and bioactive factors that support tissue regeneration and remodeling.
- dECM-based bioinks can regulate cellular functions and modulate the tissue regeneration process effectively.
- Various bioprinting techniques and decellularization methods are crucial for dECM bioink development.
Conclusions:
- dECM-based bioinks represent a promising frontier in 3D bioprinting for tissue engineering.
- Further research into dECM bioinks, bioprinting strategies, and decellularization techniques will advance tissue regeneration therapies.

